Then, the key DETF, ASCL1, and its downstream target SLC6A13 mRNA were identified, both lowly expressed in HCC tumor tissues and inhibiting the development of HCC in vitro. The gene discussed is ASCL1; the disease is hepatocellular carcinoma.